Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Amazon Explores AI Content Marketplace With Media Publishers 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Toronto, Canada, June 22, 2017 -- The Retail Council of Canada selected I-REMOVE Litramine Fat Binder to receive the 2016 Canadian Grand Prix New Product Award for Health Care–OTC (Over the Counter).
|
||||||||
"The unique and innovative formula in I-REMOVE has been the number one-selling weight management aid in Europe for the last six consecutive years,” said Jean-Philippe Sidaner, vice president of sales for Canada and Mexico. “We’re proud that after only a few months in the Canadian market, we’re helping people lose weight and live a healthier life by eating better, moving more and taking I-REMOVE.”
I-REMOVE is a premium, plant-based supplement clinically shown to deliver up to three times more weight loss than dieting alone. The product was launched by InQpharm North America in 2016 in Canada and the United States.
Now in its 24th year, the Canadian Grand Prix New Product Awards is an annual program that celebrates new products in food, non-food and private-label categories. The awards program provides a unique opportunity for entrants to showcase their new products to a jury of industry experts and be recognized by their peers. Winners are chosen based on innovation, originality and consumer acceptance. The awards encourage new product development, which is vital to the continued growth of Canada’s consumer products industry.
For more media information, please contact the Zaluvida Press Office, [email protected].
About InQpharm
InQpharm is part of the Zaluvida Group, a globally operating life science group that endeavors to rapidly develop solutions for the biggest challenges in healthcare. The company is led from its corporate offices in Switzerland and has branches in Germany, Wales, the Netherlands, the U.S., and Malaysia. By making use of unique bioactive compounds with pharma-grade efficacy, Zaluvida is a pioneer in therapies and technologies for obesity, antibiotic resistance and for the reduction of greenhouse gas emissions. Our team is united by the desire to use visionary biotech innovations to support as many people as possible in shaping a better future for themselves. For further information visit: www.zaluvida.com.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/dd19e9b3-ce69-499e-a731-57a2a0142666
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/17143534-29ff-4560-b87c-847ad4f54d4b
Cami Rozanas Zaluvida North America 801-703-2361 [email protected]
